Loading company financials…
NEW YORK STOCK EXCHANGE, INC. · Insurance · CIK 0001849253
$44.49
+5.28% · delayed ~15 min
Last price from Oct 22, 2026
$11.38B market value
From RYAN SPECIALTY HOLDINGS, INC.'s FY2025 10-K, filed Feb 13, 2026 · read the filing
It took in $2.99B last year, which makes it a mid-sized company. Of every dollar it sells, about 2 cents is left as profit.
The financial picture is led by growth, with profitability and debt worth watching.
A conclusion from the filings, not a recommendation. Detailed figures and supporting evidence appear in their dedicated sections below.
Recent open-market selling by 2 insiders, not under a pre-arranged plan.
$1.7M sold in the last 120 days · Read the filing
These are things the company filed or that a published model flagged — not predictions, and not a reason on their own to buy or sell anything.
Financial health
Generally healthy, with a few things to watch.
From RYAN SPECIALTY HOLDINGS, INC.'s FY2025 annual filing · share price scored separately
Largest year-over-year changes in FY2025
Cash
$540.2M → $158.3M
Capital spending
$0.00 → $3.0M
Revenue
$2.46B → $2.99B
Operating income
$427.8M → $493.6M
Measured against FY2024, from the 10-K filed Feb 13, 2026
Deteriorated: -70.7%
$540.2M to $158.3MCritical
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Changed: turned positive
$0.00 to $3.0MCritical
Why it matters: Neither good nor bad on its own. Heavy spending is a company building capacity or a company struggling to stand still, and the two look identical in this figure.
How the latest move compares (quote delayed ~15 min), and what was published around it
RYAN rose 5.28% on the latest quote. The average Financials company tracked here moved +1.11%, and the S&P 500 −1.04%. That is 4.2 points above its sector and 6.3 points above the market.
These coincide with the move in time. None is presented as its cause: a price can move on news that names no company, on the wider market, or on trading that no document records.
Expectations
Not from the filings — what other people are betting on, and what the price already assumes.
Opinions from 26 analysts covering this company, as of . Their views, not this site's.
Of 26 analysts publishing on this company, 5 say strong buy, 9 say buy, 11 say hold and 1 say sell. Analysts are paid to publish a view and are wrong often; the split above says how much they agree with each other, which is the part a single headline rating hides.
Published by Finnhub. Analyst coverage skews towards larger companies and towards optimism — sell ratings are rare across the whole market, so a company with none is ordinary rather than endorsed.
The essentials
Each answered from the filings, with the numbers behind it.
Yes. It keeps about 2 cents of every dollar of sales as profit, earning $63.4M last year.
Yes, quickly. Sales grew 21.9% last year.
For every $1 it owes, it owns $1.13 in assets. Banks and insurers always carry high debt — that is how lending works — so this is normal for the industry and not comparable with other sectors.
Core operating and valuation reference metrics
Whether the dividend is covered by what the business actually earns
It pays out 96 cents of every dollar of profit, which leaves little room for the payment to survive a bad year. It paid out 9% of the cash its operations generated.
MixedFigures from the FY2025 annual filing
Last year it earned $63.4M and generated $643.7M of cash from operations.
Reported annual figures
As reported to the SEC, in USD. Hover or show sources to see where each figure came from.
| Income statement | FY202510-K · Feb 13, 2026Filing for FY2025 | FY202410-K · Feb 21, 2025Filing for FY2024 | FY202310-K · Feb 21, 2025Filing for FY2023 | FY202210-K · Feb 21, 2025Filing for FY2022 | FY202110-K · Mar 16, 2022Filing for FY2021 | ChangeFY2025 vs FY2024 |
|---|---|---|---|---|---|---|
| RevenueWhat is this? | $2.99B | $2.46B | $2.03B | $1.71B | $1.43B | +21.9% |
| Selling, general and administrative | $453.5M | $352.1M | $276.2M | $197.0M | $139.0M | +28.8% |
| Operating income | $493.6M | $427.8M | $359.1M | $289.5M | $186.6M | +15.4% |
| Operating marginOperating income ÷ revenueWhat is this? | 16.5% | 17.4% | 17.7% | 16.9% | 13.0% | −0.9 pts |
| Interest expense | — | — | $119.5M | $104.8M | $79.4M | — |
| Income before tax | $293.2M | $272.6M | $237.9M | $179.2M | $61.6M | +7.6% |
| Net income | $63.4M | $94.7M | $61.0M | $61.1M | $65.9M | −33.0% |
| Net marginNet income ÷ revenueWhat is this? | 2.1% | 3.9% | 3.0% | 3.6% | 4.6% | −1.7 pts |
† calculated from other reported figures, such as total liabilities as assets minus equity.
This company's latest filing beside its peers' stored scores
| Company | Health | F-Score | Revenue growth | Profit margin | P/E | Debt to equity |
|---|---|---|---|---|---|---|
| RYANRYAN SPECIALTY HOLDINGS, INC. · this page | 7.3/10 | 5/7 |
Insider activity, ownership stakes and what's coming — straight from EDGAR, before any article is written about it
Officers, directors and major shareholders must report within two business days of a trade.
Converted a derivative security — 40,000 shares
Holds 604,235 shares after this filing.
Converted a derivative security — 40,000 shares
Holds 115,366 shares after this filing.
20 recent filings, newest first. Each is labelled from its form and item numbers, not from its wording.
Signed a material agreement
Read the filingQuarterly report for Q2 FY2026
Revenue +7.4% · Operating margin −2.8 pts · Profit -18.6% — against Q2 FY2025
Read the filingWrite down why you are following RYAN SPECIALTY HOLDINGS, INC., what has to go right and what would change your mind, then see each new annual report measured against it. Sign in to start one.
Go deeper
Every figure above traces back to a filing in the timeline, each linked to the document itself.
The 114 subsidiaries named in its 10-K, incorporated across 24 places. A filer lists the significant ones and may leave the rest out, so this is the floor rather than the full count.
Every company's figures are checked for internal consistency: the balance sheet adding up, figures sharing one currency, cash flow and share counts within plausible ranges, and how recent the latest annual report is. Nothing here changes a figure.
Financial figures are from RYAN's 10-K for fiscal year 2025 (period ending 2025-12-31, filed Feb 13, 2026), reported under the US GAAP taxonomy. View the source filing.
3 of 4 scored areas had enough reported figures to judge
The score averages profitability, growth, debt and accounting. Accounting had too few reported figures and is left out of the average rather than counted as a weakness, so a company is never marked down for a figure it did not publish. Cash generation is shown for context and already feeds profitability. Valuation is scored separately, because a share price says nothing about whether the business is sound. 7 of the 9 Piotroski checks could be evaluated. How the score works
Each year scored only from its annual report as it was first filed
| Fiscal year | Health | F-Score | Scored from |
|---|---|---|---|
| FY2025 | 7.3 | 5/7 | 10-K, filed Feb 13, 2026 |
| FY2024 | 7.3 | 4/7 | 10-K, filed Feb 21, 2025 |
| FY2023 | 7.3 | 5/7 | 10-K, filed Feb 28, 2024 |
| FY2022 | 7.3 | 5/7 | 10-K, filed Mar 1, 2023 |
| FY2021 | 7.3 | 6/7 | 10-K, filed Mar 16, 2022 |
| FY2020 | 7.3 | 3/3 | 10-K, filed Mar 16, 2022 |
A later restatement never reaches back into an earlier year, and every year is scored without a share price, so the latest point can differ a little from the headline score, which uses today's price.
Every check behind the three models, and what each one tests
5 of 7 checks passed
Nine yes-or-no tests of whether this year's finances improved on last year's. 2 could not be evaluated and are excluded from the total rather than counted as failures.
not reported — Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Distance from bankruptcy, from a model fitted on companies that did and did not go bust. It describes a balance sheet's shape today; it does not forecast a failure.
not reported — Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Screens eight accounting ratios for the pattern earnings manipulators tend to leave. A flag is a reason to read the filing closely, never evidence of wrongdoing.
Every figure above comes from the FY2025 filing as filed with the SEC.
Improved: +21.9%
$2.46B to $2.99BSignificant
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Improved: +15.4%
$427.8M to $493.6MSignificant
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Deteriorated: -33.0%
$94.7M to $63.4MSignificant
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: +24.4%
$514.9M to $640.7MSignificant
Why it matters: Cash left after paying for the plant that produced it — the money genuinely available for dividends, buybacks or paying down debt. Harder to flatter than profit.
Changed: -23.9%
$80.2M to $61.0MSignificant
Why it matters: Cash handed to shareholders. A rise can be a higher dividend or simply more shares, and a cut is a decision the company explains in its own filing — neither is rated here.
Deteriorated: −1.7 pts
3.9% to 2.1%Notable
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Q2 FY2026 against Q2 FY2025, from the 10-Q filed Jul 31, 2026 — read it.
Deteriorated: -18.6%
$52.0M to $42.3MSignificant
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Deteriorated: -18.8%
$172.6M to $140.1MSignificant
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Improved: +7.4%
$840.9M to $902.7MNotable
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Deteriorated: -5.6%
$191.1M to $180.3MNotable
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Deteriorated: −2.8 pts
22.7% to 20.0%Notable
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Deteriorated: −1.5 pts
6.2% to 4.7%Notable
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Q2 FY2026 against Q1 FY2026, from the 10-Q filed Jul 31, 2026 — read it. Quarter-to-quarter moves include seasonal swings — a retailer's holiday quarter — which the year-earlier comparison removes.
Improved: +90.6%
$94.6M to $180.3MCritical
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Improved: +139.8%
$17.6M to $42.3MCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: +15.3%
$782.9M to $902.7MSignificant
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Improved: +7.9 pts
12.1% to 20.0%Significant
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Improved: +2.4 pts
2.3% to 4.7%Notable
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Deteriorated: -9.4%
$154.7M to $140.1MNotable
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
2 other measures barely moved. Figures compare the two most recent annual filings — read the latest one. Moves are graded on fixed lines — 5%, 15% and 40% for amounts, and 1, 3 and 8 points for margins — as notable, significant or critical. Nothing here reads the management commentary, which is where a company explains its own numbers.
Filter by minute, hour, day or week — or compare against peers
Loading price history…
Measured on and published about a week later — this is a fortnightly snapshot, not a live position.
About 5.1% of this company's shares have been borrowed and sold by people expecting to buy them back cheaper. That is a bet the price falls. Those people can be wrong, and when a heavily shorted share rises they have to buy it back, which pushes it up further.
Collected by FINRA from broker-dealers twice a month. It counts positions, not intentions, and some of it is hedging rather than a directional bet against the company.
Nothing in this section is a figure this company reported about itself. These are expectations and positions — what the price implies, what analysts have published, what short sellers are betting, and what large funds held at the last count. WylthIQ reports them; it does not endorse them, does not forecast prices, and takes no view on whether any of them will turn out to be right.
The trailing P/E is 79.6x — a high multiple relative to the current trailing profit.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
| 21.9% |
| 2.1% |
| 179.51x |
| 14.37x |
| MRSHMARSH & MCLENNAN COMPANIES, INC. | 7.3/10 | 7/8 | 10.3% | 15.4% | 23.23x | 2.83x |
|---|
| AJGArthur J. Gallagher & Co. | 8.7/10 | 6/8 | 20.7% | 10.7% | 46.61x | 2.03x |
|---|
| BROBROWN & BROWN, INC. | 8.7/10 | 4/8 | 22.8% | 17.9% | 23.75x | 1.39x |
|---|
| Median of peers | 8.7/10 | — | 20.7% | 15.4% | 23.75x | 2.03x |
|---|
Peers come from the company's industry classification. A difference describes the companies; it does not rank them.
Sold on the open market — 40,000 shares at $40.51 ($1.6M)
Holds 75,366 shares after this filing.
Reported another kind of transaction — 1,841,019 shares
Holds 1,841,020 shares after this filing.
Reported another kind of transaction — 313,116 shares
Holds 313,116 shares after this filing.
Sold on the open market — 2,043 shares at $42.26 ($86.3K)
Holds 8,153 shares after this filing.
Gifted shares — 3,000 shares
Holds 24,795 shares after this filing.
Exercised stock options — 5,821 shares
Holds 20,395 shares after this filing.
Had shares withheld to cover taxes — 1,706 shares at $40.89 ($69.8K)
Holds 18,689 shares after this filing.
Notice filed ahead of a planned sale — the sale itself has not necessarily happened yet.
Filed notice to sell 40,000 shares ($1.6M) on or after .
Shares originally obtained via Conversion of Pre IPO Incentive Equity into LLC Units of Post IPO UP-C Corporate Structure.
Filed notice to sell 2,043 shares ($86.3K) on or after .
Shares originally obtained via Restricted Stock Vesting Under a Registered Plan.
Not investment advice, and not a signal to act on by itself — a filing says what happened, not why, and insiders trade for ordinary reasons having nothing to do with where they think the company is headed.
Published results · Reported another event
Made a Regulation FD disclosure
Read the filingHeld a shareholder vote
Read the filingQuarterly report for Q1 FY2026
Revenue +15.8% · Operating margin −2.7 pts · Profit turned positive — against Q1 FY2025
Read the filingSigned a material agreement
Read the filingPublished results · Reported another event
Read the filingProxy statement for a shareholder meeting
Read the filingAnnual report for FY2025
Revenue +21.9% · Profit margin −1.7 pts · Cash -70.7% — against FY2024
Read the filingAnnounced restructuring or exit costs · Published results · Made a Regulation FD disclosure · Reported another event
Read the filingReceived shareholder director nominations · Reported another event
Read the filingHad a director or senior officer leave or join · Made a Regulation FD disclosure
Read the filingQuarterly report for Q3 FY2025
Revenue +25.7% · Operating margin +1.1 pts · Profit +76.7% — against Q3 FY2024
Read the filingPublished results · Reported another event
Read the filingHad a director or senior officer leave or join · Made a Regulation FD disclosure
Read the filingHad a director or senior officer leave or join
Read the filingQuarterly report for Q2 FY2025
Revenue +23.6% · Operating margin −1.4 pts · Long-term debt +75.7% — against Q2 FY2025
Read the filingPublished results · Reported another event
Read the filingReported another event
Read the filingThe first 40 of 114. The rest are in the exhibit.
Source: Exhibit 21 of the 10-K filed 2026-02-13. These are legal entities, not brands or acquisitions — a company that bought a business may hold it inside an entity named here, or inside one small enough that the rule does not require naming it at all.
Coverage from the last 30 days
Ryan Specialty Group (RYAN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Yahoo ·
Marsh shares are trading higher after the company reported better-than-expected Q1 financial results.
Benzinga ·
Wells Fargo Maintains Equal-Weight on Ryan Specialty Holdings, Lowers Price Target to $41
Benzinga ·
1 of Wall Street’s Favorite Stocks for Long-Term Investors and 2 We Avoid
Yahoo ·
Mizuho Maintains Neutral on Ryan Specialty Holdings, Lowers Price Target to $40
Benzinga ·
General Motors To Rally Around 40%? Here Are 10 Top Analyst Forecasts For Tuesday
Benzinga ·
Piper Sandler Maintains Neutral on Ryan Specialty Holdings, Lowers Price Target to $40
Benzinga ·
Ryan Specialty to Announce Third Quarter 2026 Financial Results on Thursday, October 29, 2026
Yahoo ·
Pricing Cycle Pressure Weighed on Ryan Specialty (RYAN)
Yahoo ·
Ryan Specialty Shares Gain 9% in 3 Months: What's Driving the Rally?
Yahoo ·
Primary sources and further research